Ipratropium Bromide And Albuterol Sulfate recalls

Ipratropium Bromide And Albuterol Sulfate products have been recalled 4 times, most recently on 1 May 2024. The recalling company is usually Nephron Pharmaceuticals. The most common reason is sterility.

Total recalls4since 2015

Last 12 months0reported

Class I00% of total

Ongoing0latest 1 May 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 3 75%Class III 1 25%

Why ipratropium bromide and albuterol sulfate is recalled

Companies

Nephron Pharmaceuticals125%
Mckesson Medical-Surgical Inc. Corporate Office125%
Cardinal Healthcare125%
Cipla USA125%

Product types

Inhalers & Asthma Medication4100%

By year

2024250%
2022125%
2015125%

All ipratropium bromide and albuterol sulfate recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
1 May 2024Drug	CLASS II	Ipratropium Bromide and Albuterol Sulfate Inhalation recalledIpratropium Bromide And Albuterol Sulfate	Cipla USA	Packaging Defects	Nationwide
3 Jan 2024Drug	CLASS II	Ipratropium Bromide and Albuterol Sulfate Inhalation recalledIpratropium Bromide And Albuterol Sulfate	Cardinal Healthcare	Sterility	Nationwide
15 Jun 2022Drug	CLASS III	Ipratropium Bromide 5 mg and Albuterol Sulfate 3 mg recalledIpratropium Bromide And Albuterol Sulfate	Mckesson Medical-Surgical Inc. Corporate Office	Manufacturing (CGMP) Deviations	Nationwide
21 Oct 2015Drug	CLASS II	Ipratropium Bromide 5 mg and Albuterol Sulfate 3 mg recalledIpratropium Bromide And Albuterol Sulfate	Nephron Pharmaceuticals	Sterility	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.